D
아이티켐
309710KOSDAQ기초 의약물질 제조업38.0 / 100
Reference Date: 2026-06-10
Financial Score10.5 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Itechem is a CDMO/CMO company with over 20 years of experience, producing pharmaceutical APIs and intermediates, as well as display materials like OLEDs, supplying high-purity products to global clients under K-GMP certification. The company focuses on organic synthesis technology and is expanding into next-generation drug development, including oligonucleotides and oligopeptides.
Number of Employees
133people
Average Salary
55.1M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 27.714.0Point
PBR
4.11Industry Average 1.740.0Point
2.4x industry avg (risky)
ROE
-25.43Industry Average -6.033.5Point
4.2x industry avg (excellent)
Debt Ratio
76.71Industry Average 6.620.0Point
11.6x industry avg (risky)
Trend 3.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
0.0 / 4
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (10%, downtrend)
Current 21,000Won52-week high 49,70052-week low 17,620
1-month return3.0Point
1m 0% (flat)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral분기보고서 (2026.03)2026-06-01